Shine-On BioMedical Co (ROCO:6926) Interest Expense : NT$-0.03 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Shine-On BioMedical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shine-On BioMedical Co's interest expense for the six months ended in Dec. 2024 was NT$ -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-0.03 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shine-On BioMedical Co's Operating Income for the six months ended in Dec. 2024 was NT$ -81.78 Mil. Shine-On BioMedical Co's Interest Expense for the six months ended in Dec. 2024 was NT$ -0.02 Mil. Shine-On BioMedical Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shine-On BioMedical Co Interest Expense Historical Data

The historical data trend for Shine-On BioMedical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shine-On BioMedical Co Interest Expense Chart

Shine-On BioMedical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.02

-0.03

-0.01

-0.03

Shine-On BioMedical Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial				-0.01	-0.01	-	-0.01	-0.02

Shine-On BioMedical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.03 Mil.

Shine-On BioMedical Co (ROCO:6926) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shine-On BioMedical Co's Interest Expense for the six months ended in Dec. 2024 was NT$-0.02 Mil. Its Operating Income for the six months ended in Dec. 2024 was NT$-81.78 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was NT$1.36 Mil.

Shine-On BioMedical Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Shine-On BioMedical Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Shine-On BioMedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shine-On BioMedical Co Ltd (ROCO:6926) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 633, Section 2, Taiwan Avenue, Unit 6, 5th Floor, Xitun District, Taichung, TWN

Website

https://www.shineon-bio.com

Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with the most effective cancer treatment options.

Shine-On BioMedical Co Headlines

No Headlines